Ovalith 10BP
510(k) K781377
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK781377 | Date4 Dec 1978 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Ovalith 10BP is an Implantable Pacemaker Pulse-Generator, designed to regulate cardiac rhythm in patients with bradycardia or conduction disorders. This device delivers electrical impulses to stimulate the heart when native pacing is insufficient, ensuring consistent and reliable cardiac output.
Supplied as a single-use, implantable device, the Ovalith 10BP is intended for sterile surgical implantation by qualified medical professionals. It is classified under FDA 510(k) clearance (K781377) and falls under Device Class III (DXY), adhering to regulatory standards for cardiovascular implants. Storage and handling must comply with sterile medical device protocols.
Other devices from Coratomic, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the Ovalith 10BP used for in clinical practice?
The Ovalith 10BP is an implantable pacemaker pulse-generator designed to regulate cardiac rhythm in patients with bradycardia or conduction disorders. It delivers electrical impulses to stimulate the heart when the body’s natural pacing system is insufficient, ensuring steady cardiac output for patients who require chronic cardiac support.
Is the Ovalith 10BP intended for single-use or can it be reused?
The Ovalith 10BP is explicitly supplied as a single-use device. It is intended for sterile surgical implantation by qualified medical professionals and should not be reused after one procedure to maintain patient safety and sterility.
How should the Ovalith 10BP be stored and handled?
The Ovalith 10BP must be stored and handled according to sterile medical device protocols. Since it is implantable, it is provided in a sterile packaging to ensure it remains uncontaminated before use in the operating room.
What regulatory pathway was followed for the Ovalith 10BP’s approval?
The Ovalith 10BP received FDA clearance through a 510(k) submission (K781377) under the Traditional clearance type. It was reviewed by the FDA’s Cardiovascular (CV) Advisory Committee and classified as a Class III device (DXY), adhering to strict regulatory standards for cardiovascular implants.